Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001013594-23-000250
Filing Date
2023-02-14
Accepted
2023-02-14 16:16:23
Documents
1

Document Format Files

Seq Description Document Type Size
1 lifecore13ga1-021423.htm SC 13G/A 90341
  Complete submission text file 0001013594-23-000250.txt   91901
Mailing Address 3515 LYMAN BOULEVARD CHASKA MN 55318
Business Address 3515 LYMAN BOULEVARD CHASKA MN 55318 9523684300
LIFECORE BIOMEDICAL, INC. \DE\ (Subject) CIK: 0001005286 (see all company filings)

EIN.: 943025618 | State of Incorp.: DE | Fiscal Year End: 0528
Type: SC 13G/A | Act: 34 | File No.: 005-45181 | Film No.: 23629554
SIC: 2834 Pharmaceutical Preparations

Mailing Address 590 MADISON AVENUE 21ST FLOOR NEW YORK NY 10022
Business Address 590 MADISON AVENUE 21ST FLOOR NEW YORK NY 10022 646-775-4394
ISZO CAPITAL LP (Filed by) CIK: 0001484190 (see all company filings)

EIN.: 271649960 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A